Anish Suri
2019
In 2019, Anish Suri earned a total compensation of $4.6M as President and Chief Scientific Officer at Cue Biopharma, a 42% increase compared to previous year.
Compensation breakdown
| Bonus | $376,524 |
|---|---|
| Option Awards | $3,059,956 |
| Salary | $366,250 |
| Stock Awards | $753,000 |
| Other | $4,084 |
| Total | $4,559,814 |
Suri received $3.1M in option awards, accounting for 67% of the total pay in 2019.
Suri also received $376.5K in bonus, $366.3K in salary, $753K in stock awards and $4.1K in other compensation.
Rankings
In 2019, Anish Suri's compensation ranked 2,509th out of 13,971 executives tracked by ExecPay. In other words, Suri earned more than 82.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,509 out of 13,971 | 82nd |
Division Manufacturing | 901 out of 5,701 | 84th |
Major group Chemicals And Allied Products | 292 out of 2,200 | 87th |
Industry group Drugs | 236 out of 1,886 | 88th |
Industry Pharmaceutical Preparations | 173 out of 1,398 | 88th |
Source: SEC filing on May 29, 2020.
Suri's colleagues
We found three more compensation records of executives who worked with Anish Suri at Cue Biopharma in 2019.